| Product Code: ETC9506780 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import of blood clotting factors in 2024 saw a shift in concentration, with a very high concentration among the top exporting countries compared to the previous year. Peru, Netherlands, USA, Brazil, and Germany were the key contributors to these import shipments. Despite a negative growth rate of -8.75% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.08%. This data suggests a dynamic market for blood clotting factors in Suriname, with fluctuations in growth rates and concentration among key exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Blood Clotting Factor Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Blood Clotting Factor Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Blood Clotting Factor Market - Industry Life Cycle |
3.4 Suriname Blood Clotting Factor Market - Porter's Five Forces |
3.5 Suriname Blood Clotting Factor Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Suriname Blood Clotting Factor Market Revenues & Volume Share, By Test, 2022 & 2032F |
3.7 Suriname Blood Clotting Factor Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Suriname Blood Clotting Factor Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Suriname Blood Clotting Factor Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Suriname Blood Clotting Factor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Blood Clotting Factor Market Trends |
6 Suriname Blood Clotting Factor Market, By Types |
6.1 Suriname Blood Clotting Factor Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Blood Clotting Factor Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Suriname Blood Clotting Factor Market Revenues & Volume, By Clinical Laboratory Analysers, 2022 - 2032F |
6.1.4 Suriname Blood Clotting Factor Market Revenues & Volume, By Point-Of-Care Testing Analysers, 2022 - 2032F |
6.2 Suriname Blood Clotting Factor Market, By Test |
6.2.1 Overview and Analysis |
6.2.2 Suriname Blood Clotting Factor Market Revenues & Volume, By Prothrombin Time Testing, 2022 - 2032F |
6.2.3 Suriname Blood Clotting Factor Market Revenues & Volume, By Fibrinogen Testing, 2022 - 2032F |
6.2.4 Suriname Blood Clotting Factor Market Revenues & Volume, By Activated Partial Thromboplastin Time Testing, 2022 - 2032F |
6.2.5 Suriname Blood Clotting Factor Market Revenues & Volume, By Activated Clotting Time Testing, 2022 - 2032F |
6.2.6 Suriname Blood Clotting Factor Market Revenues & Volume, By D-Dimer Testing, 2022 - 2032F |
6.2.7 Suriname Blood Clotting Factor Market Revenues & Volume, By Platelet Function Tests, 2022 - 2032F |
6.2.8 Suriname Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2022 - 2032F |
6.2.9 Suriname Blood Clotting Factor Market Revenues & Volume, By Heparin and Protamine Dose Response Tests for ACT, 2022 - 2032F |
6.3 Suriname Blood Clotting Factor Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Suriname Blood Clotting Factor Market Revenues & Volume, By Mechanical Technology, 2022 - 2032F |
6.3.3 Suriname Blood Clotting Factor Market Revenues & Volume, By Optical Technology, 2022 - 2032F |
6.3.4 Suriname Blood Clotting Factor Market Revenues & Volume, By Electrochemical Technology, 2022 - 2032F |
6.3.5 Suriname Blood Clotting Factor Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Suriname Blood Clotting Factor Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Suriname Blood Clotting Factor Market Revenues & Volume, By Bleeding Disorders, 2022 - 2032F |
6.4.3 Suriname Blood Clotting Factor Market Revenues & Volume, By Acquired Bleeding Disorders, 2022 - 2032F |
6.4.4 Suriname Blood Clotting Factor Market Revenues & Volume, By Von Willebrand Disease, 2022 - 2032F |
6.4.5 Suriname Blood Clotting Factor Market Revenues & Volume, By Haemophilia, 2022 - 2032F |
6.5 Suriname Blood Clotting Factor Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Suriname Blood Clotting Factor Market Revenues & Volume, By Academic Institutions, 2022 - 2032F |
6.5.3 Suriname Blood Clotting Factor Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.5.4 Suriname Blood Clotting Factor Market Revenues & Volume, By Diagnostic Laboratories, 2022 - 2032F |
6.5.5 Suriname Blood Clotting Factor Market Revenues & Volume, By Others, 2022 - 2032F |
7 Suriname Blood Clotting Factor Market Import-Export Trade Statistics |
7.1 Suriname Blood Clotting Factor Market Export to Major Countries |
7.2 Suriname Blood Clotting Factor Market Imports from Major Countries |
8 Suriname Blood Clotting Factor Market Key Performance Indicators |
9 Suriname Blood Clotting Factor Market - Opportunity Assessment |
9.1 Suriname Blood Clotting Factor Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Suriname Blood Clotting Factor Market Opportunity Assessment, By Test, 2022 & 2032F |
9.3 Suriname Blood Clotting Factor Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.4 Suriname Blood Clotting Factor Market Opportunity Assessment, By Application, 2022 & 2032F |
9.5 Suriname Blood Clotting Factor Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Suriname Blood Clotting Factor Market - Competitive Landscape |
10.1 Suriname Blood Clotting Factor Market Revenue Share, By Companies, 2025 |
10.2 Suriname Blood Clotting Factor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here